Absorption, Metabolism, and Excretion of [14C]-Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Following a Single Oral Dose in Healthy Male Subjects Posted on September 29, 2021 at 1:34 pm.Written by Spero Therapeutics View Presentation Post navigation Empiric Antimicrobial Prescribing for Urinary Tract Infections in Patients Discharged from the Emergency DepartmentHigh Prevalence of Fluoroquinolone-Resistant Urinary Tract Infection Among US Emergency Department Patients Diagnosed with UTI, 2018-2020
